1. Harrer, Philip, Škorvánek, Matej, Kittke, Volker, Winkelmann, Juliane, Zech, Michael. 2023. Dystonia Linked to EIF4A2 Haploinsufficiency: A Disorder of Protein Translation Dysfunction. In Movement disorders : official journal of the Movement Disorder Society, 38, 1914-1924. doi:10.1002/mds.29562. https://pubmed.ncbi.nlm.nih.gov/37485550/
2. Paul, Maimuna S, Duncan, Anna R, Genetti, Casie A, Chao, Hsiao-Tuan, Agrawal, Pankaj B. 2022. Rare EIF4A2 variants are associated with a neurodevelopmental disorder characterized by intellectual disability, hypotonia, and epilepsy. In American journal of human genetics, 110, 120-145. doi:10.1016/j.ajhg.2022.11.011. https://pubmed.ncbi.nlm.nih.gov/36528028/
3. Li, Dan, Yang, Jihong, Huang, Xin, Zhou, Hongwei, Wang, Jianlong. 2022. eIF4A2 targets developmental potency and histone H3.3 transcripts for translational control of stem cell pluripotency. In Science advances, 8, eabm0478. doi:10.1126/sciadv.abm0478. https://pubmed.ncbi.nlm.nih.gov/35353581/
4. Song, Zhenhui, Yang, Yang, Wang, Li, Yuan, Peng, Yu, Qiuhan. 2018. EIF4A2 interacts with the membrane protein of transmissible gastroenteritis coronavirus and plays a role in virus replication. In Research in veterinary science, 123, 39-46. doi:10.1016/j.rvsc.2018.12.005. https://pubmed.ncbi.nlm.nih.gov/30583231/
5. Lyu, Shanshan, Lu, Jiabin, Chen, Wendan, Xi, Shaoyan, Yan, Shumei. 2020. High expression of eIF4A2 is associated with a poor prognosis in esophageal squamous cell carcinoma. In Oncology letters, 20, 177. doi:10.3892/ol.2020.12038. https://pubmed.ncbi.nlm.nih.gov/32934744/